BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24937835)

  • 1. Case for diagnosis.
    Sampaio FM; Gualberto GV; Cerqueira FG; Cerqueira AM; Treu CM; Vargas TJ
    An Bras Dermatol; 2014; 89(3):519-20. PubMed ID: 24937835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High proliferative activity excludes dermatofibroma: report of the utility of MIB-1 in the differential diagnosis of selected fibrohistiocytic tumors.
    Hanly AJ; Jordà M; Elgart GW; Badiavas E; Nassiri M; Nadji M
    Arch Pathol Lab Med; 2006 Jun; 130(6):831-4. PubMed ID: 16740036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An unusual case of deep penetrating dermatofibroma of the lower leg. Case report.
    Rainer C; Schwabegger A; Anderl H; Zelger B
    Scand J Plast Reconstr Surg Hand Surg; 1998 Dec; 32(4):429-32. PubMed ID: 9862112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Giant cell fibroblastoma in a child misdiagnosed as a dermatofibroma.
    Nguyen CM; Burch JM; Fitzpatrick JE; Peterson SL; Weston WL
    Pediatr Dermatol; 2002; 19(1):28-32. PubMed ID: 11860566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fibrohistiocytic tumors of the skin: a heterogeneous group of superficially located mesenchymal neoplasms].
    Mentzel T
    Pathologe; 2015 Feb; 36(1):79-88. PubMed ID: 25589356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fibrohistiocytic skin tumors].
    Hügel H
    J Dtsch Dermatol Ges; 2006 Jul; 4(7):544-55. PubMed ID: 16827912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrophic variants of dermatofibroma and dermatofibrosarcoma protuberans.
    Zelger BW; Ofner D; Zelger BG
    Histopathology; 1995 Jun; 26(6):519-27. PubMed ID: 7545142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrohistiocytic Tumors.
    Romano RC; Fritchie KJ
    Clin Lab Med; 2017 Sep; 37(3):603-631. PubMed ID: 28802503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tenascin expression in cutaneous fibrohistiocytic tumors. Immunohistochemical investigation of 24 cases.
    Franchi A; Santucci M
    Am J Dermatopathol; 1996 Oct; 18(5):454-9. PubMed ID: 8902090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible contribution of PDGF-BB-induced autophagy in dermatofibrosarcoma protuberans: Autophagy marker Atg5 could be a differential marker between dermatofibrosarcoma protuberans and dermatofibroma.
    Motegi SI; Fujiwara C; Sekiguchi A; Yamazaki S; Yokoyama Y; Yasuda M; Ishikawa O
    J Dermatol Sci; 2019 Feb; 93(2):139-141. PubMed ID: 30704939
    [No Abstract]   [Full Text] [Related]  

  • 11. LN-2 (CD74). A marker to distinguish atypical fibroxanthoma from malignant fibrous histiocytoma.
    Lazova R; Moynes R; May D; Scott G
    Cancer; 1997 Jun; 79(11):2115-24. PubMed ID: 9179057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep penetrating dermatofibroma.
    Laughlin CL; Carrington PR
    Dermatol Surg; 1998 May; 24(5):592-4. PubMed ID: 9598017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low proliferative activity in common dermatofibroma does not necessarily guarantee a low proliferation in all dermatofibroma variants.
    Fernandez-Flores A
    Arch Pathol Lab Med; 2008 Feb; 132(2):160; author reply 160-1. PubMed ID: 18251566
    [No Abstract]   [Full Text] [Related]  

  • 14. Cutaneous mesenchymal tumours: an update.
    Mentzel T
    Pathology; 2014 Feb; 46(2):149-59. PubMed ID: 24378387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myxoid dermatofibroma on a great toe: a case report.
    Moon A; Yoon N; Kim HS
    Int J Clin Exp Pathol; 2015; 8(6):7605-9. PubMed ID: 26261677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variants of dermatofibroma--a histopathological study.
    Alves JV; Matos DM; Barreiros HF; Bártolo EA
    An Bras Dermatol; 2014; 89(3):472-7. PubMed ID: 24937822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastasising dermatofibroma or dermatofibroma-like dermatofibrosarcoma protuberans?
    Dunkin CS; MacGregor AB; McLaren K
    J R Coll Surg Edinb; 2000 Apr; 45(2):132-4. PubMed ID: 10822924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous atypical fibrous histiocytoma.
    Garrido-Ruiz MC; Ramos P; Enguita AB; Rodriguez Peralto JL
    Am J Dermatopathol; 2009 Jul; 31(5):499-501. PubMed ID: 19542931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The ultrastructure of fibrous and histiocytic skin tumors (dermatofibroma, dermatofibrosarcoma protuberans, fibroxanthoma, and histiocytoma) (author's transl)].
    Auböck L
    Virchows Arch A Pathol Anat Histol; 1975 Oct; 368(3):253-74. PubMed ID: 171831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. When Immunohistochemistry Deceives Us: The Pitfalls of CD34 and Factor XIIIa Stains in Dermatofibroma and Dermatofibrosarcoma Protuberans.
    John AM; Holahan HH; Singh P; Handler MZ; Lambert WC
    Skinmed; 2017; 15(1):53-55. PubMed ID: 28270311
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.